Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices

• US 6,591,133 B1
• Filed: 11/27/2000
• Issued: 07/08/2003
• Est. Priority Date: 11/27/2000
• Status: Expired due to Fees

• Current Assignee: Microlin LLC
• Original Assignee: Microlin LLC
• Inventors: Joshi, Ashok V.
• Primary Examiner(s): Lazarus, Ira S.
• Assistant Examiner(s): Ragonese, Andrea M.
• Application Number:
  US09/723,230
• Time in Patent Office: 953 Days
• Field of Search: 604/890.1, 604/891.1, 604/892.1, 604/19-21, 604/27, 604/30, 604/36, 604/289
• US Class Current: 604/21
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

The invention includes apparatus and methods for electrotransport of a drug or other beneficial agent through a skin or mucosal membrane surface. In one embodiment, at least one of the cathode or anode electrode of an electrochemical cell is configured, at least in part, as an electroactive needle for insertion all or part way through the stratum corneum of a patient'"'"'s skin. A reservoir containing a beneficial agent may be provided in fluid communication with one or more electroactive needles, in which case the electroactive needle(s) may be configured with a hollow bore interior for transport of the beneficial agent directly into a subject'"'"'s tissues. In a related embodiment, an electroactive needle is configured for intravenous and/or intramuscular use. The invention also includes an electrotransport system comprising an electrochemically active porous substrate. In a further embodiment, the invention comprises an electrotransport system having one or more implantable active porous electrodes.

Claims

1. An electrotransport apparatus for delivery of a drug or other beneficial agent through a body surface of a subject, comprising:

an electrochemical cell having an electrochemically active cathode and an electrochemically active anode;

at least a portion of at least one of the electrochemically active cathode and the electrochemically active anode configured as at least one electroactive needle,

wherein the at least one electroactive needle is configured for conducting current in relation to the body surface and for delivering the drug or other beneficial agent across the subject'"'"'s body surface; and

a conductor for electrically interconnecting the electrochemically active cathode with the electrochemically active anode;

wherein said electrochemically active anode and said electrochemically active cathode form a power source for said electrotransport apparatus.

2. The electrotransport apparatus of claim 1, wherein the at least one electroactive needle is configured for the delivery of the drug or other beneficial agent in liquid form.

3. The electrotransport apparatus of claim 2, wherein the at least one electroactive needle is adapted for insertion into a skin surface by manual compression.

4. The electrotransport apparatus of claim 3, wherein the at least one electroactive needle is adapted for one of intravenous and intramuscular delivery of the drug or other beneficial agent.

5. The electrotransport apparatus of claim 1, wherein at least one of the electrochemically active cathode and the electrochemically active anode comprises a plurality of electroactive needles.

6. The electrotransport apparatus of claim 1, wherein at least a portion of each of the electrochemically active cathode and the electrochemically active anode are formed of the at least one electroactive needle.

7. The electrotransport apparatus of claim 1, further comprising a drug or other beneficial agent reservoir attached proximate at least one of the electrochemically active cathode and the electrochemically active anode.

8. The electrotransport apparatus of claim 7, wherein the drug or other beneficial agent reservoir is attached proximate the at least one electroactive needle and in fluid communication therewith.

9. The electrotransport apparatus of claim 8, wherein the drug or other beneficial agent reservoir comprises a standard medication cartridge.

10. The electrotransport apparatus of claim 1, further comprising an additional power source electrically interconnected to the electrochemically active cathode and the electrochemically active anode.

11. The electrotransport apparatus of claim 1, further comprising a second electrochemical cell connected in series with the electrochemical cell.

12. The electrotransport apparatus of claim 1, wherein at least a portion of each of the electrochemically active cathode and the electrochemically active anode are configured as a plurality of electroactive needles.

13. The electrotransport apparatus of claim 1, wherein the electrochemically active anode is formed of an electrochemically active metal, and wherein the electrochemically active cathode is formed of a material selected from the group consisting of electrochemically active oxides, halides, and chalcogenides.

14. The electrotransport apparatus of claim 13, wherein the electrochemically active anode is formed of a metal selected from the group consisting of Zn, Mg, Ca, Ba, Sn, Fe, their alloys, and mixtures of any thereof.

15. The electrotransport apparatus of claim 13, wherein the electrochemically active cathode is formed of a material selected from the group consisting of carbon, active metal oxides, and mixtures and composites of any thereof.

16. The electrotransport apparatus of claim 13, wherein the active metal oxides are selected from the group comprising silver oxides, copper oxides, manganese dioxides, and mixtures and composites of any thereof.

17. The electrotransport apparatus of claim 1, further comprising a controller configured to regulate voltage passing between the electrochemically active cathode and the electrochemically active anode.

18. The electrotransport apparatus of claim 17, wherein the controller comprises a battery and a resistor interposed in an electrical interconnection extending between the electrochemically active cathode and the electrochemically active anode.

19. The electrotransport apparatus of claim 1, wherein the at least one electroactive needle is associated with a compound having anti-microbial activity.

20. The electrotransport apparatus of claim 1, wherein at least a portion of the at least one electroactive needle is coated with a polymer.

30. The electrotransport apparatus of claim 1, wherein the electrochemical cell consists essentially of the electrochemically active cathode and the electrochemically active anode.

21. An improved transdermal delivery apparatus of the type in which an electrochemically active anode is configured to conduct current in relation to a first skin surface, an electrochemically active cathode is configured to provide an electric current in relation to a second skin surface, a conductor for electrically interconnecting the electrochemically active anode with the electrochemically active cathode, and in which a reservoir containing a drug or beneficial agent is attached adjacent at least one of the electrochemically active anode and the electrochemically active cathode, wherein the improvement comprises:

at least a portion of at least one of the electrochemically active anode and the electrochemically active cathode configured as at least one electroactive needle configured and adapted to penetrate at least a portion of a stratum corneum layer of a subject;

wherein said electrochemically active anode and said electrochemically active cathode form a power source for said transdermal delivery apparatus.

22. The improved transdermal delivery apparatus of claim 21, wherein the at least one electroactive needle is configured for conducting current in relation to a body surface of the subject and for delivering the drug or other beneficial agent through the body surface of the subject.

23. A method of electrically facilitating the transport of a drug or other beneficial agent through body tissues of a subject, comprising:

providing an anode configured to conduct current in relation to a first skin surface;

providing a cathode configured to conduct current in relation to a second skin surface,

at least a portion of at least one of said cathode and said anode being configured as at least one electroactive needle of a predetermined length sufficient to penetrate at least a portion of a stratum corneum layer of the subject;

providing at least one conductor for electrically interconnecting said anode with said cathode, said at least one conductor extending between said anode and said cathode;

providing a drug or other beneficial agent reservoir disposed adjacent and in fluid communication with an electrically conducting area of at least one of said anode and said cathode;

inserting said electroactive needle a predetermined distance into a skin surface to electrochemically activate said anode and said cathode;

electrochemically generating a voltage from said activation of said anode and said cathode; and

delivering said voltage to body tissues of the subject, said voltage facilitating the transport of the drug or other beneficial agent through said body tissues of the subject;

wherein said anode and said cathode form a power source for facilitating the transport of the drug or other beneficial agent.

24. The method according to claim 23, wherein said delivering said voltage to body tissues of the subject comprises conducting said voltage through said at least one electroactive needle.

25. The method according to claim 23, further comprising transporting the drug or other beneficial agent to the body tissues of the subject through a passageway in said electroactive needle.

26. The method of claim 25, wherein said transporting the drug or other beneficial agent comprises transporting the drug or other beneficial agent in liquid form.

27. The method of claim 26, wherein inserting the at least one electroactive needle comprises inserting the at least one electroactive needle into said skin surface by manual compression.

28. The method of claim 23, further comprising lessening electrically resistive barriers of a portion of the stratum corneum by subjecting the portion of the stratum corneum to micro-piercing by microparticles.

29. In a method of fabricating an electrotransport assembly for facilitating the transport of a drug or other beneficial agent through a skin surface, of the type wherein an electrochemically active anode is configured to conduct current in relation to a first skin surface, an electrochemically active cathode is configured to provide an electric current in relation to a second skin surface, an electrical interconnection between the electrochemically active cathode and the electrochemically active cathode, and in which a reservoir containing a drug or beneficial agent is attached adjacent and in fluid communication with at least one of the electrochemically active anode and the electrochemically active cathode, the improvement comprising:

configuring at least a portion of at least one of the electrochemically active anode and the electrochemically active cathode as an electroactive needle for penetrating at least a portion of a stratum corneum layer of a subject;

wherein said electrochemically active anode and said electrochemically active cathode form a power source for said electrotransport assembly.